| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | 633 | 26.940 | 112.700 | 149.151 | 186.702 |
| Total Income - EUR | - | - | - | - | - | 633 | 26.940 | 112.700 | 149.524 | 188.057 |
| Total Expenses - EUR | - | - | - | - | - | 1.666 | 14.838 | 59.548 | 95.963 | 123.192 |
| Gross Profit/Loss - EUR | - | - | - | - | - | -1.033 | 12.102 | 53.152 | 53.560 | 64.866 |
| Net Profit/Loss - EUR | - | - | - | - | - | -1.058 | 11.375 | 51.862 | 52.289 | 60.891 |
| Employees | - | - | - | - | - | 0 | 0 | 0 | 1 | 1 |
Check the financial reports for the company - Terre-Optic Medical Design S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | 0 | 2.288 | 7.249 | 8.766 | 8.012 |
| Current Assets | - | - | - | - | - | 2.631 | 9.620 | 87.808 | 65.041 | 125.933 |
| Inventories | - | - | - | - | - | 2.559 | 453 | 11.776 | 18.840 | 14.001 |
| Receivables | - | - | - | - | - | 0 | 461 | 37.311 | 9.640 | 14.542 |
| Cash | - | - | - | - | - | 71 | 8.706 | 38.720 | 36.561 | 97.390 |
| Shareholders Funds | - | - | - | - | - | -1.017 | 10.381 | 51.911 | 71.424 | 131.917 |
| Social Capital | - | - | - | - | - | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | 3.647 | 1.528 | 43.146 | 2.382 | 2.028 |
| Income in Advance | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8690 - 8690" | |||||||||
| CAEN Financial Year |
8690
|
|||||||||
Comments - Terre-Optic Medical Design S.r.l.